ATF6 and amyloidosis: This further highlights the potential for enhancing the activity of key ER quality control factors including BiP or PDIA4 through mechanisms such as ATF6 activation to ameliorate pathologic extracellular aggregation of TTR implicated in amyloid disease pathogenesis.